Ferroptosis-related NFE2L2 and NOX4 Genes are Potential Risk Prognostic Biomarkers and Correlated with Immunogenic Features in Glioma

Cell Biochem Biophys. 2023 Mar;81(1):7-17. doi: 10.1007/s12013-022-01124-x. Epub 2023 Jan 11.

Abstract

Ferroptosis is a newfound mode of regulated cell death that may have potential to associate with prognostic or diagnostic factors in glioma. In this research, 5 genes related to glioma were screened through the FerrDb database, and we analyzed the combination between genes and glioma of survival and prognosis via TCGA, GEPIA, TIMER, and other databases. Survival curve and prognostic analysis showed that the overexpression of NFE2L2 and NOX4, respectively, has a remarkable link with a worse prognosis in glioma. Then, the association between the expression of the two genes and tumor-infiltrating immune cells level was explored based on the GSCA, and the immunity of NFE2L2 and NOX4 based on the TISIDB database was also investigated. In glioma, especially GBM, there is a strong association between gene expression and immune infiltration, even in macrophages, nTreg, and Th2 cells, which play immunosuppressive functions in TME. In conclusion, these results indicate that NFE2L2 and NOX4 could be risk prognosis biomarkers in glioma, and they bound up with immune infiltration and tumor immunity in tumorigenesis.

Keywords: Ferroptosis; Glioma; Immune infiltration; Prognostic biomarker.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Biomarkers, Tumor / genetics
  • Carcinogenesis
  • Ferroptosis* / genetics
  • Glioma* / genetics
  • Humans
  • NADPH Oxidase 4 / genetics
  • NF-E2-Related Factor 2 / genetics
  • Prognosis

Substances

  • Biomarkers
  • Biomarkers, Tumor
  • NOX4 protein, human
  • NADPH Oxidase 4
  • NFE2L2 protein, human
  • NF-E2-Related Factor 2